Matches in SemOpenAlex for { <https://semopenalex.org/work/W4221008429> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W4221008429 endingPage "63" @default.
- W4221008429 startingPage "56" @default.
- W4221008429 abstract "Background: Patients admitted with acute exacerbation of Chronic Obstructive Pulmonary Disease (COPD) are often prescribed ipratropium bromide in combination with a β2 agonist like salbutamol. Many studies have not shown any benefit in adding ipratropium bromide to salbutamol in acute exacerbations of COPD. Objectives: To compare the response of combination therapy with two drugs vs. salbutamol alone in the treatment of acute exacerbations of COPD during hospital admission. Materials and Methods: This cross-sectional comparative study was conducted among one hundred patients of acute exacerbation of COPD admitted in Rajshahi Medical College Hospital from January 2012 to July 2012. The patients were randomly allocated to receive either solution-1 (salbutamol 5mg alone) or solution-2 (salbutamol 5mg plus ipratropium bromide 500μgm) (all four times a day) on admission. All other treatment was prescribed at the discretion of the attending physician.FEV1 and FVC values at baseline, at 1 hour, on day 1, day three, and on discharge date were assessed. Patients completed a subjective symptom score at 1 hour, Day 1, Day 3, and on the discharge date. Length of stay in hospital was assessed. Results: There was no significant difference in spirometric values at 1 hour, Day 1, Day 3, and during discharge between the two groups. The subjective improvement was similar with both treatments. There was no difference between the two groups in the mean (±SD) length of hospital stay (salbutamol 5.98(±1.67) days, salbutamol plus ipratropium bromide 5.8(±1.39) days; t=0.586, p>0.05). Conclusion: The routine addition of nebulized ipratropium bromide to salbutamol appears to be of no benefit in the treatment of acute exacerbations of COPD. TAJ 2021; 34: No-2: 56-63" @default.
- W4221008429 created "2022-04-03" @default.
- W4221008429 creator A5032249379 @default.
- W4221008429 creator A5041963777 @default.
- W4221008429 creator A5056904975 @default.
- W4221008429 creator A5057949957 @default.
- W4221008429 creator A5073065821 @default.
- W4221008429 creator A5081646206 @default.
- W4221008429 date "2022-03-08" @default.
- W4221008429 modified "2023-09-25" @default.
- W4221008429 title "Comparison of Bronchodilator Response of Nebulized Salbutamol with Nebulized Salbutamol and Ipratropium Bromide in Patients with Acute Exacerbation of Advanced COPD" @default.
- W4221008429 doi "https://doi.org/10.3329/taj.v34i2.58556" @default.
- W4221008429 hasPublicationYear "2022" @default.
- W4221008429 type Work @default.
- W4221008429 citedByCount "0" @default.
- W4221008429 crossrefType "journal-article" @default.
- W4221008429 hasAuthorship W4221008429A5032249379 @default.
- W4221008429 hasAuthorship W4221008429A5041963777 @default.
- W4221008429 hasAuthorship W4221008429A5056904975 @default.
- W4221008429 hasAuthorship W4221008429A5057949957 @default.
- W4221008429 hasAuthorship W4221008429A5073065821 @default.
- W4221008429 hasAuthorship W4221008429A5081646206 @default.
- W4221008429 hasBestOaLocation W42210084291 @default.
- W4221008429 hasConcept C126322002 @default.
- W4221008429 hasConcept C2776042228 @default.
- W4221008429 hasConcept C2776780178 @default.
- W4221008429 hasConcept C2777014857 @default.
- W4221008429 hasConcept C2777394947 @default.
- W4221008429 hasConcept C2780532441 @default.
- W4221008429 hasConcept C2781018748 @default.
- W4221008429 hasConcept C2909577894 @default.
- W4221008429 hasConcept C42219234 @default.
- W4221008429 hasConcept C71924100 @default.
- W4221008429 hasConceptScore W4221008429C126322002 @default.
- W4221008429 hasConceptScore W4221008429C2776042228 @default.
- W4221008429 hasConceptScore W4221008429C2776780178 @default.
- W4221008429 hasConceptScore W4221008429C2777014857 @default.
- W4221008429 hasConceptScore W4221008429C2777394947 @default.
- W4221008429 hasConceptScore W4221008429C2780532441 @default.
- W4221008429 hasConceptScore W4221008429C2781018748 @default.
- W4221008429 hasConceptScore W4221008429C2909577894 @default.
- W4221008429 hasConceptScore W4221008429C42219234 @default.
- W4221008429 hasConceptScore W4221008429C71924100 @default.
- W4221008429 hasIssue "2" @default.
- W4221008429 hasLocation W42210084291 @default.
- W4221008429 hasOpenAccess W4221008429 @default.
- W4221008429 hasPrimaryLocation W42210084291 @default.
- W4221008429 hasRelatedWork W1983057355 @default.
- W4221008429 hasRelatedWork W1983679397 @default.
- W4221008429 hasRelatedWork W1988797668 @default.
- W4221008429 hasRelatedWork W2037570395 @default.
- W4221008429 hasRelatedWork W2103198607 @default.
- W4221008429 hasRelatedWork W2130255350 @default.
- W4221008429 hasRelatedWork W2159775904 @default.
- W4221008429 hasRelatedWork W2981074094 @default.
- W4221008429 hasRelatedWork W4221008429 @default.
- W4221008429 hasRelatedWork W2531817857 @default.
- W4221008429 hasVolume "34" @default.
- W4221008429 isParatext "false" @default.
- W4221008429 isRetracted "false" @default.
- W4221008429 workType "article" @default.